aclacinomycin has been researched along with Experimental Leukemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hirano, S; Hori, S; Inui, T; Ishizuka, M; Oki, T; Shirai, M; Takeuchi, T; Tsukagoshi, S; Umezawa, H | 1 |
| Carman, MD; Gamba-Vitalo, C; Sartorelli, AC | 1 |
2 other study(ies) available for aclacinomycin and Experimental Leukemia
| Article | Year |
|---|---|
Antitumor activity of new anthracycline antibiotics, aclacinomycin-A and its analogs, and their toxicity.
Topics: Aclarubicin; Animals; Anthraquinones; Antibiotics, Antineoplastic; Cricetinae; Daunorubicin; Doxorubicin; Electrocardiography; Glycosides; Heart; Leukemia L1210; Leukemia, Experimental; Lymphoma, Non-Hodgkin; Male; Mesocricetus; Mice; Mice, Inbred Strains; Sarcoma 180; Sarcoma, Experimental; Streptomyces | 1977 |
WEHI-3B D+ Y1 leukemia cells as a model system to assess the induction of differentiation in vivo.
Topics: Aclarubicin; Animals; Antineoplastic Agents; Cell Differentiation; Cell Line; Hematopoiesis; Kanamycin Kinase; Leukemia, Experimental; Mice; Mice, Inbred BALB C; Nucleic Acid Hybridization; Phosphotransferases; RNA, Messenger; Transfection | 1989 |